Once in a Blue Moon Academia (OBMA)

  Between Cosmetic Grooming, Pharmacology and DHFL Haircut: Ambiguities in the Case of Bohem by Piramal Pharma Limited Posted on 25th October, 2025 (GMT 06:16 hrs) ABSTRACT This paper investigates the regulatory and ethical positioning of Bohem, a men’s grooming product line launched by Piramal Pharma Limited (PPL), within the Indian cosmetic–drug regulatory framework. Drawing upon publicly available documents from the Central Drugs Standard Control Organisation (CDSCO), Piramal Pharma’s corporate communications, and state regulatory norms, the study demonstrates that Bohem—while branded under a major pharmaceutical conglomerate—is not a pharmacologically approved medicine. Rather, it is classified as a cosmetic or personal-care product, subject to the relatively lenient provisions of the Cosmetics Rules 2020. The analysis underscores how blurred categorizations between cosmetics and therapeutics enable large corporations to exploit brand trust associated with pharmaceutical c...

    Urgent Call to Reassess Piramal Pharma’s Tetmosol Soap A Case for Halting Its Sale Due to Global Questions, Misuse Risks and Ethical Concerns Posted on 1st October, 2025 (GMT 18:11 hrs) ABSTRACT Tetmosol soap, marketed by Piramal Pharma Limited as a treatment for scabies and lice, contains the outdated active ingredient Monosulfiram (5% w/w). While effective for its intended use, Tetmosol’s widespread over-the-counter (OTC) availability in India and other developing regions, coupled with vague marketing claims, has led to rampant misuse for undiagnosed dermatological conditions. This misuse risks ineffective treatment, skin irritation, and delayed diagnoses, raising serious concerns about consumer safety and Mr. Piramal’s ethical responsibility. The article critically examines Tetmosol’s composition, safety, regulatory status, consumer misuse, and Mr. Piramal’s marketing practices, alongside broader enforcement challenges and Mr. Piramal’s product portfolio. It argues...